Lorlatinib Impurity 30 | CAS 2107318-87-4 - Request Quote
Lorlatinib Impurity 30
| SZ CAT No: | SZ-L054043 |
| CAS No | 2107318-87-4 |
| Mol.F. | C15H22FNO2 |
| Mol.Wt. | 267.3 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Lorlatinib Impurity 30 is chemically (S)-4-fluoro-2-(1-hydroxyethyl)-N,N-diisopropylbenzamide. Lorlatinib Impurity 30 is supplied with detailed characterization data compliant with regulatory guideline. Lorlatinib Impurity 30 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Lorlatinib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 2107318-87-4
Purchase 2107318-87-4
Order 2107318-87-4
Enquire 2107318-87-4
price of 2107318-87-4
2107318-87-4 Supplier
2107318-87-4 Manufacturer
2107318-87-4 Exporter
buy high quality Lorlatinib Impurity 30
Purchase Lorlatinib Impurity 30
Lorlatinib Impurity 30 suppliers
Lorlatinib Impurity 30 manufacturers
Lorlatinib Impurity 30 price
Order Lorlatinib Impurity 30
Enquire Lorlatinib Impurity 30
Lorlatinib Impurity 30 cost
Lorlatinib Impurity 30 Supplier
Lorlatinib Impurity 30 Distributor
Lorlatinib Impurity 30 for Method Validation
Lorlatinib Reference Standard
Lorlatinib Impurity 30 for ANDA Filing
Lorlatinib Impurity 30 for Forced Degradation Studies
Lorlatinib Impurity 30 Identification Standards
Lorlatinib Impurity 30 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


